Angela M Krackhardt
12PUBLICATIONS
59CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Dec 02, 2025
Tempered signal strength via low-dose MEK inhibition optimizes therapeutic performance of engineered T cells.Franziska Füchsl, Antonia Schwanzer, Melanie Faber
|Jul 10, 2025
Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens.Leonie Rieger, Kilian Irlinger, Franziska Füchsl
|Dec 03, 2024
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells.Franziska Füchsl, Johannes Untch, Vladyslav Kavaka
|Mar 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro
|Aug 02, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro
|Sep 09, 2022
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment.Franziska Füchsl, Angela M Krackhardt
Pageof 2
Frequent Collaborators
6 joint publications
Roland Rad
5 joint publications
Franziska Füchsl
4 joint publications
Mathias Wilhelm
4 joint publications
Celina Tretter
4 joint publications
Florian Bassermann
4 joint publications
Gabriela Zuleger
4 joint publications
Bernhard Kuster
4 joint publications
Katja Steiger
3 joint publications
Niklas de Andrade Krätzig
3 joint publications
Johannes Untch
